About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland

March 25, 2015

Click here to read more

Post navigation

Appendix 4E Preliminary Final Financial Report

Phosphagenics Appoints Three New Directors

Related Posts

First Patient Dosed in Phase III Insomnia Trial

May 16, 2024May 16, 2024

Phosphagenics Begins its Animal Health and Nutrition Program

September 28, 2015

Athenex takes Avecho’s Vitamin K injection to FDA pre-IND meeting

January 12, 2023January 12, 2023

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.